+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Enflurane Market by Route of Administration, End-Use - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967854
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Enflurane Market grew from USD 206.39 million in 2023 to USD 215.70 million in 2024. It is expected to continue growing at a CAGR of 4.59%, reaching USD 282.70 million by 2030.

Enflurane, an inhalational anesthetic, is primarily used for inducing and maintaining general anesthesia during surgeries. Its necessity stems from its ability to provide controlled and reversible loss of consciousness, making it valuable in medical settings. The primary application of Enflurane is within hospitals and surgical centers, catering to patients undergoing various surgical procedures. The end-use scope further extends to ambulatory surgical centers due to the growing trend of outpatient surgeries, driven by advancements in medical technologies. The market for Enflurane is influenced by factors such as increasing surgical procedures globally, advancements in anesthesia delivery systems, and rising awareness about anesthetic practices. Potential opportunities lie in emerging markets with growing healthcare infrastructure, presenting a chance for anesthesia manufacturers to expand their foothold. Companies can capitalize on research focusing on improving the safety profile of Enflurane and minimizing side effects, paving the way for superior anesthetic solutions. However, the market faces limitations such as strict regulatory frameworks and the decline in preference for some anesthetics due to the emergence of newer alternatives with improved safety and efficacy profiles. Additionally, concerns about the potential environmental impact of anesthetic gases could pose challenges to market growth. Innovations could target developing eco-friendly anesthetic solutions or enhancing drug delivery systems for improved patient outcomes. Further research into safer formulations and exploring combination therapies might provide additional growth avenues. The nature of the market is competitive, with prominent pharmaceutical companies focusing on product enhancement and compliance with stringent regulations to maintain market leadership. Overall, continuous innovation, strategic partnerships, and regulatory adaptability are essential for sustaining growth in the Enflurane market.

Understanding Market Dynamics in the Enflurane Market

The Enflurane Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising incidences of chronic diseases and accidents globally
    • Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
  • Market Restraints
    • Emergence of newer and advanced anesthetic agents
  • Market Opportunities
    • Technological innovations in anesthesia delivery and monitoring techniques
    • Ongoing research into biodegradable, eco-friendly alternatives
  • Market Challenges
    • Regulatory scrutiny and stringent guidelines governing the use of enflurane

Exploring Porter’s Five Forces for the Enflurane Market

Porter’s Five Forces framework further strengthens the insights of the Enflurane Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Enflurane Market

External macro-environmental factors deeply influence the performance of the Enflurane Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Enflurane Market

The Enflurane Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Enflurane Market

The Enflurane Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Enflurane Market

The Enflurane Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Drägerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Enflurane Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Route of Administration
    • Inhalation
    • Oral
  • End-Use
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidences of chronic diseases and accidents globally
5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
5.1.2. Restraints
5.1.2.1. Emergence of newer and advanced anesthetic agents
5.1.3. Opportunities
5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
5.1.4. Challenges
5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
5.2. Market Segmentation Analysis
5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
5.2.2. End-Use: Evolving usage of enflurane by hospitals
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Enflurane Market, by Route of Administration
6.1. Introduction
6.2. Inhalation
6.3. Oral
7. Enflurane Market, by End-Use
7.1. Introduction
7.2. Ambulatory Surgical Centers
7.3. Hospitals
8. Americas Enflurane Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Enflurane Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Enflurane Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. ENFLURANE MARKET DYNAMICS
TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 20. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 21. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 22. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 23. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 32. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 33. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 34. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 38. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 39. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 58. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 60. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 61. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 63. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 66. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 69. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 70. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 75. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 79. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 94. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 100. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Enflurane Market, which are profiled in this report, include:
  • AbbVie Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Drägerwerk AG & Co. KGaA
  • GE HealthCare Technologies Inc.
  • Hikma Pharmaceuticals PLC
  • J&TEC CO., LTD.
  • Sanofi S.A.

Methodology

Loading
LOADING...

Table Information